← All organizations

Highest phase reached
Phase 2
First clinical trial
Apr 1, 2015Last known activity
Aug 31, 2025
Acquired by Diffusion Pharmaceuticals LLC on Aug 16, 2023
Timeline
2010s
- Jun 1, 2014
EIP Pharma, LLC— Founded
2020s
- Aug 16, 2023
Diffusion Pharmaceuticals LLC— Acquired By
Drugs by trial phase (2 distinct, 9 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT07033481Lead sponsorPhase 2Aug 31, 2025
- NCT06987643Lead sponsorPhase 2Jun 20, 2025
- NCT06815965Lead sponsorPhase 2Oct 16, 2024
- NCT05869669Lead sponsorPhase 2May 1, 2023
- NCT03980938Lead sponsorPhase 2Jun 30, 2019
- NCT04001517Study directorPhase 2Jun 30, 2019
- NCT03980938Study directorPhase 2Jun 30, 2019
- NCT04001517Lead sponsorPhase 2Jun 30, 2019
- NCT03402659Lead sponsorPhase 2Dec 29, 2017
- NCT03402659Study directorPhase 2Dec 29, 2017
- NCT02423122Lead sponsorPhase 2Apr 1, 2015
- NCT02423200Lead sponsorPhase 2Apr 1, 2015
Details
- Founded
- Cambridge, MA, US Jun 1, 2014
- Last known activity
- Aug 31, 2025